Matrix Capital Management Company, LP 13D and 13G filings for Maze Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 4:10 pm Sale | 2025-09-30 | 13G | Maze Therapeutics, Inc. MAZE | Matrix Capital Management Company, LP | 1,653,684 3.500% | -832,500 (-33.49%) | Filing |
| 2025-05-14 4:10 pm Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | Matrix Capital Management Company, LP | 2,486,184 5.700% | 2,486,184 (New Position) | Filing |